---
document_datetime: 2023-09-21 21:42:57
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/ikervis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: ikervis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 12.2949597
conversion_datetime: 2025-12-20 13:07:49.317776
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## IKERVIS

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ² / amended on   | Product Information affected3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| N/0035               | Minor change in labelling or package leaflet not connected with the SPC(Art.61.3 Notification)                         | 27/02/2023                          |                                            | PL                              |           |
| IB/0034              | B.II.b.5.z -Change to in-process tests or limits applied during the manufacture of the finished product-Othervariation | 31/01/2023                          | n/a                                        |                                 |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

2A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics,annex II, labelling,package leaflet).The CD is issued within twomonths of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation(EU) No.712/2012, or within one yearfor other procedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IAIN/0033           | B.II.b.1.a-Replacement or addition of a manufacturingsitefortheFp-Secondarypackaging site                                                                                                                                                                                                                                                                                                                                                               | 05/12/2022   | n/a        |                        |                                |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|--------------------------------|
| PSUSA/10362 /202203 | PeriodicSafetyUpdateEUSingle assessment- ciclosporin (topical use)                                                                                                                                                                                                                                                                                                                                                                                      | 27/10/2022   | n/a        |                        | PRACRecommendation-maintenance |
| IB/0032             | B.II.c.2.d-Change in test procedure for an excipient - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                                                                            | 04/10/2022   | n/a        |                        |                                |
| IA/0031/G           | This was an application for a group of variations. B.III.2.b-ChangetocomplywithPh.Eur.orwitha nationalpharmacopoeiaofaMemberState-Change tocomplywithanupdateof therelevantmonograph of thePh.Eur.or national pharmacopoeia ofa MemberState B.III.1.a.2-Submission of a new/updated or deletionofPh.Eur.CertificateofSuitabilitytothe relevantPh.Eur.Monograph-Updatedcertificate fromanalreadyapprovedmanufacturer A.7-Administrativechange-Deletionof | 20/09/2022   | n/a        |                        |                                |
| IB/0029             | B.II.f.1.d - Stability of FP - Change in storage conditionsofthefinishedproductorthe diluted/reconstituted product                                                                                                                                                                                                                                                                                                                                      | 24/01/2022   | 28/11/2022 | SmPC, Labelling and PL |                                |
| I1/0026/G           | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                                                                                      | 16/12/2021   | 28/11/2022 | SmPC,                  |                                |

<div style=\"page-break-after: always\"></div>

|                     | B.II.e.1.b.2 - Change in immediate packaging of the finishedproduct-Change in type/additionof a new container-Sterilemedicinalproducts and biological/immunological medicinal products B.II.e.5.d - Change in pack size of the finished product - Change in the fill weight/fill volume of nonparenteral multi-dose (or single-dose, partial use)products B.II.e.4.c-Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products B.II.e.5.d-Change in pack size of the finished product - Change in the fill weight/fill volume of nonparenteral multi-dose(or single-dose,partial use) products   |            |     | Labelling and PL   |                                |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|--------------------------------|
| PSUSA/10362 /202103 | PeriodicSafetyUpdateEUSingle assessment- ciclosporin (topical use)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 28/10/2021 | n/a |                    | PRACRecommendation-maintenance |
| IB/0028             | B.II.c.1.z-Change in the specification parameters and/or limits of an excipient-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 14/07/2021 | n/a |                    |                                |
| PSUSA/10362 /202009 | PeriodicSafetyUpdateEUSingleassessment- ciclosporin (topical use)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 09/04/2021 | n/a |                    | PRACRecommendation-maintenance |
| IG/1315             | B.II.b.5.a -Change to in-process tests or limits applied during the manufacture of the finished product -Tightening of in-processlimits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 08/03/2021 | n/a |                    |                                |
| PSUSA/10362         | PeriodicSafetyUpdateEUSingle assessment-                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 01/10/2020 | n/a |                    | PRACRecommendation-maintenance |

<div style=\"page-break-after: always\"></div>

| /202003             | ciclosporin (topical use)                                                                                                                                                                                                                                                                                                                 |            |            |                                  |                                                                                                                                                                                                                                                          |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0023             | B.III.1.z-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate of Suitability-Other variation                                                                                                                                                                                                                                 | 21/07/2020 | n/a        |                                  |                                                                                                                                                                                                                                                          |
| PSUSA/10362 /201909 | PeriodicSafetyUpdateEU Single assessment - ciclosporin (topical use)                                                                                                                                                                                                                                                                      | 17/04/2020 | n/a        |                                  | PRACRecommendation-maintenance                                                                                                                                                                                                                           |
| IG/1227/G           | Thiswasanapplicationforagroupofvariations. A.5.a-Administrative change-Change in the name and/or addressof amanufacturer/importer responsibleforbatchrelease B.III.1.a.2-Submission of a new/updated or deletionofPh.Eur.CertificateofSuitabilitytothe relevantPh.Eur.Monograph-Updated certificate from an already approved manufacturer | 15/04/2020 | 26/03/2021 | SmPC, Annex II and PL            |                                                                                                                                                                                                                                                          |
| R/0017              | Renewalof themarketing authorisation.                                                                                                                                                                                                                                                                                                     | 13/02/2020 | 09/03/2020 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, theCHMPconsidered thatthebenefit-riskbalanceof IKERVIS in the approved indication remains favourable and thereforerecommendedtherenewalofthemarketing authorisation with unlimitedvalidity. |
| 11/0018             | B.II.d.1.e - Change in the specification parameters and/orlimitsofthefinishedproduct-Change outside the approved specifications limits range                                                                                                                                                                                              | 20/02/2020 | n/a        |                                  |                                                                                                                                                                                                                                                          |
| IG/1163/G           | This was an applicationfor a group of variations. A.7-Administrativechange-Deletionof                                                                                                                                                                                                                                                     | 21/11/2019 | n/a        |                                  |                                                                                                                                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|                     | manufacturing sites B.II.c.3.z-Change in source of an excipient or reagent with TSErisk-Other variation B.III.1.a.2-Submission of a new/updated or deletion ofPh.Eur.Certificateof Suitabilitytothe relevant Ph.Eur.Monograph-Updated certificate from an already approved manufacturer                                                                                                                            |            |            |                        |                                |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------|
| PSUSA/10362 /201903 | PeriodicSafetyUpdateEUSingleassessment- ciclosporin (topical use)                                                                                                                                                                                                                                                                                                                                                  | 03/10/2019 | n/a        |                        | PRACRecommendation-maintenance |
| WS/1490             | This was an applicationfor avariationfollowing a worksharingprocedure according toArticle20of CommissionRegulation(EC)No1234/2008. C.1.11.b -Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,including the RMP-Implementation of change(s)whichrequire tobefurthersubstantiated bynewadditional data tobesubmittedby theMAH where significant assessment is required | 29/05/2019 | 04/07/2019 | SmPC, Labelling and PL |                                |
| PSUSA/10362 /201809 | Periodic Safety Update EU Single assessment - ciclosporin (topical use)                                                                                                                                                                                                                                                                                                                                            | 11/04/2019 | n/a        |                        | PRACRecommendation-maintenance |
| PSUSA/10362 /201803 | PeriodicSafetyUpdateEUSingle assessment- ciclosporin (topical use)                                                                                                                                                                                                                                                                                                                                                 | 04/10/2018 | n/a        |                        | PRACRecommendation-maintenance |
| PSUSA/10362 /201709 | PeriodicSafetyUpdateEUSingleassessment- ciclosporin (topical use)                                                                                                                                                                                                                                                                                                                                                  | 12/04/2018 | n/a        |                        | PRACRecommendation-maintenance |

<div style=\"page-break-after: always\"></div>

| IB/0010             | B.II.e.z - Change in container closure system of the FinishedProduct-Othervariation                                                                                                                                                                                                                                                                                 | 07/12/2017   | n/a        |                        |                                |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|--------------------------------|
| PSUSA/10362 /201703 | Periodic Safety Update EU Single assessment - ciclosporin (topical use)                                                                                                                                                                                                                                                                                             | 28/09/2017   | n/a        |                        | PRACRecommendation-maintenance |
| PSUSA/10362 /201609 | PeriodicSafetyUpdateEUSingle assessment- ciclosporin (topical use)                                                                                                                                                                                                                                                                                                  | 06/04/2017   | n/a        |                        | PRACRecommendation-maintenance |
| IAIN/0008/G         | Thiswasanapplicationforagroupofvariations. B.II.b.1.a-Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.c.1-Change toimporter,batchrelease arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsibleforimportation and/orbatchrelease- Not including batch control/testing | 09/01/2017   | 29/06/2017 | Annex II and PL        |                                |
| PSUSA/10362 /201603 | PeriodicSafetyUpdateEUSingle assessment- ciclosporin (topical use)                                                                                                                                                                                                                                                                                                  | 29/09/2016   | n/a        |                        | PRACRecommendation-maintenance |
| I1/0005             | Update ofsections5.1-Pharmacodynamic properties of the SmPC in order to include an efficacy andsafetysummaryresultsregardingPost-SANSIKA study(StudyNVG12D122)-\"Multicenter,open label, interventional, prospective, non-randomized, onecohortextensionstudytoassessthe sustainabilityoftheeffectofNOvA220071mg/mlin SevereDryEyeDisease(DED)following              | 21/07/2016   | 29/06/2017 | SmPC, Labelling and PL |                                |

<div style=\"page-break-after: always\"></div>

|                     | discontinuation of treatment inimprovedpatients\" In addition,the Marketing authorisationholder (MAH)tooktheopportunitytointroduceeditorial changes in the SmPC, Annex IIA and Annex IIIB C.I.4-Change(s)in theSPC,Labelling orPLdue to new quality, preclinical, clinical or pharmacovigilance data   |            |            |                        |                                |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------|
| PSUSA/10362 /201509 | PeriodicSafetyUpdateEUSingle assessment - ciclosporin (topical use)                                                                                                                                                                                                                                   | 14/04/2016 | n/a        |                        | PRACRecommendation-maintenance |
| N/0004              | Minor change in labelling or package leaflet not connectedwiththeSPC(Art.61.3Notification)                                                                                                                                                                                                            | 16/12/2015 | 29/06/2017 | PL                     |                                |
| IAIN/0002           | B.II.b.1.a-Replacement or addition of a manufacturingsitefortheFp-Secondarypackaging site                                                                                                                                                                                                             | 21/10/2015 | n/a        |                        |                                |
| T/0001              | MarketingAuthorisationTransferfromSantenS.A.S toSantenOy. TransferofMarketingAuthorisation                                                                                                                                                                                                            | 13/05/2015 | 11/06/2015 | SmPC, Labelling and PL |                                |